Stoke Therapeutics Inc (STOK)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
8.60 +0.49 (+6.04%) 03/14/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 8.60 unch (unch) 16:03 ET
for Fri, Mar 14th, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -104,699 | -101,067 | -85,805 | -52,243 | -32,325 |
| Depreciation Amortization | 2,144 | 1,335 | 1,117 | 888 | 450 |
| Other Working Capital | -6,030 | 43,023 | 46 | 2,325 | -1,105 |
| Other Operating Activity | 27,518 | 24,843 | 17,735 | 6,809 | 1,925 |
| Operating Cash Flow | $-81,067 | $-31,866 | $-66,907 | $-42,221 | $-31,055 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,616 | -3,962 | -1,200 | -1,050 | -1,634 |
| Purchase Of Investment | N/A | -201,320 | -87,226 | N/A | N/A |
| Sale Of Investment | 107,562 | 159,400 | 12,000 | N/A | N/A |
| Investing Cash Flow | $105,946 | $-45,882 | $-76,426 | $-1,050 | $-1,634 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 52,452 | 45,838 | 777 | 108,241 | 152,227 |
| Other Financing Activity | 555 | 571 | 507 | -133 | -2,465 |
| Financing Cash Flow | $53,007 | $46,409 | $1,284 | $108,108 | $149,762 |
| Beginning Cash Position | 114,125 | 145,464 | 287,513 | 222,676 | 105,603 |
| End Cash Position | 192,011 | 114,125 | 145,464 | 287,513 | 222,676 |
| Net Cash Flow | $77,886 | $-31,339 | $-142,049 | $64,837 | $117,073 |
| Free Cash Flow | |||||
| Operating Cash Flow | -81,067 | -31,866 | -66,907 | -42,221 | -31,055 |
| Capital Expenditure | -1,616 | -3,962 | -1,200 | -1,050 | -1,635 |
| Free Cash Flow | -82,683 | -35,828 | -68,107 | -43,271 | -32,690 |